IDEC Pharmaceuticals' Merger

IDEC Pharmaceuticals raised a round of funding on June 25, 2003. Investors include Biogen.

Producer of antibody-based treatment for lymphoma. The company completed an IPO and later merged with Biogen (Nasdaq: BIIB).…

Articles about IDEC Pharmaceuticals' Merger: